Header Logo

Connection

Rosemary Zuna to Papillomavirus Infections

This is a "connection" page, showing publications Rosemary Zuna has written about Papillomavirus Infections.
Connection Strength

4.589
  1. Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathol. 2018 11; 126(11):950-958.
    View in: PubMed
    Score: 0.543
  2. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer. 2009 Dec 01; 125(11):2609-13.
    View in: PubMed
    Score: 0.293
  3. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod Pathol. 2007 Feb; 20(2):167-74.
    View in: PubMed
    Score: 0.239
  4. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 2006 Oct 25; 108(5):288-97.
    View in: PubMed
    Score: 0.236
  5. Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer. 2005 Oct 25; 105(5):253-62.
    View in: PubMed
    Score: 0.221
  6. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. J Natl Cancer Inst. 2022 06 13; 114(6):845-853.
    View in: PubMed
    Score: 0.175
  7. HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract. Am J Surg Pathol. 2022 06 01; 46(6):729-741.
    View in: PubMed
    Score: 0.170
  8. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor. Mod Pathol. 2001 Mar; 14(3):147-51.
    View in: PubMed
    Score: 0.160
  9. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. J Natl Cancer Inst. 2021 01 04; 113(1):72-79.
    View in: PubMed
    Score: 0.158
  10. Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020 11 15; 147(10):2677-2686.
    View in: PubMed
    Score: 0.151
  11. Identification of HPV genotypes causing cervical precancer using tissue-based genotyping. Int J Cancer. 2020 05 15; 146(10):2836-2844.
    View in: PubMed
    Score: 0.149
  12. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat Commun. 2020 02 14; 11(1):886.
    View in: PubMed
    Score: 0.149
  13. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. J Infect Dis. 2019 10 08; 220(10):1609-1619.
    View in: PubMed
    Score: 0.145
  14. Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing. J Clin Microbiol. 2019 05; 57(5).
    View in: PubMed
    Score: 0.141
  15. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Res. 2019 06; 7:67-74.
    View in: PubMed
    Score: 0.139
  16. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018 06; 218(6):604.e1-604.e8.
    View in: PubMed
    Score: 0.130
  17. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 2017 Sep 07; 170(6):1164-1174.e6.
    View in: PubMed
    Score: 0.126
  18. Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have =CIN2. Int J Cancer. 2017 Feb 01; 140(3):718-725.
    View in: PubMed
    Score: 0.118
  19. Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. Carcinogenesis. 2016 Feb; 37(2):188-196.
    View in: PubMed
    Score: 0.111
  20. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015 Jun 23; 112(25):E3255-64.
    View in: PubMed
    Score: 0.107
  21. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol. 2014 Aug; 60(4):414-7.
    View in: PubMed
    Score: 0.100
  22. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2014 Jan; 52(1):187-92.
    View in: PubMed
    Score: 0.096
  23. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. Int J Cancer. 2014 Jan 15; 134(2):411-25.
    View in: PubMed
    Score: 0.094
  24. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013 Feb; 128(2):265-70.
    View in: PubMed
    Score: 0.090
  25. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer. 2013 Jan 01; 132(1):148-54.
    View in: PubMed
    Score: 0.087
  26. Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol. 2012 May; 50(5):1564-70.
    View in: PubMed
    Score: 0.085
  27. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
    View in: PubMed
    Score: 0.073
  28. Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology. 2009 Aug 01; 390(2):261-7.
    View in: PubMed
    Score: 0.071
  29. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
    View in: PubMed
    Score: 0.069
  30. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol. 2005 Nov; 79(21):13630-40.
    View in: PubMed
    Score: 0.055
  31. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer. 2017 08 15; 141(4):701-710.
    View in: PubMed
    Score: 0.031
  32. A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 05; 145(2):291-297.
    View in: PubMed
    Score: 0.030
  33. Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 01; 33(1):83-9.
    View in: PubMed
    Score: 0.026
  34. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012 Aug 01; 18(15):4154-62.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.